The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Lizneva D.V.

Kafedra akusherstva i ginekologii IPO Samarskogo gosudarstvennogo meditsinskogo universiteta;
ZAO "Meditsinskaia kompaniia IDK", Samara

Sinitsyna A.I.

Kafedra akusherstva i ginekologii IPO Samarskogo gosudarstvennogo meditsinskogo universiteta;
ZAO "Meditsinskaia kompaniia IDK", Samara

FUNDAMENTAL AND CLINICAL CHARACTERISTICS OF NATURAL ESTROGENS AS A PART OF MODERN COMBINED ORAL CONTRACEPTION (A REVIEW)

Authors:

Lizneva D.V., Sinitsyna A.I.

More about the authors

Journal: Russian Journal of Human Reproduction. 2012;(5): 22‑26

Read: 4059 times

Contact the author
Table of contents

FUNDAMENTAL AND CLINICAL CHARACTERISTICS OF NATURAL ESTROGENS AS A PART OF MODERN COMBINED ORAL CONTRACEPTION (A REVIEW)
FUNDAMENTAL AND CLINICAL CHARACTERISTICS OF NATURAL ESTROGENS AS A PART OF MODERN COMBINED ORAL CONTRACEPTION (A REVIEW)

To cite this article:

Lizneva DV, Sinitsyna AI. FUNDAMENTAL AND CLINICAL CHARACTERISTICS OF NATURAL ESTROGENS AS A PART OF MODERN COMBINED ORAL CONTRACEPTION (A REVIEW). Russian Journal of Human Reproduction. 2012;(5):22‑26. (In Russ.)

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Lipid profile indi­cators and their ratios in patients with non-ST elevation acute coro­nary syndrome. Russian Cardiology Bulletin. 2025;(3):48-53
Features of urokinase pharmacokinetics at subtherapeutic doses. Russian Cardiology Bulletin. 2025;(4-2):112-116
Abstract:

This review presents recent data on the specifics aspects of the pharmacokinetics, metabolism, and biological effects of natural estrogens used in combined oral contraceptives.

Keywords:

contraception
estradiol
estradiol valerate
pharmacokinetics
lipids
carbohydrat

Authors:

Lizneva D.V.

Kafedra akusherstva i ginekologii IPO Samarskogo gosudarstvennogo meditsinskogo universiteta;
ZAO "Meditsinskaia kompaniia IDK", Samara

Sinitsyna A.I.

Kafedra akusherstva i ginekologii IPO Samarskogo gosudarstvennogo meditsinskogo universiteta;
ZAO "Meditsinskaia kompaniia IDK", Samara

Close metadata

References:

  1. Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 2005; 8: Suppl 1: 3-63.
  2. Aedo A.R., Landgren B.M., Diczfalusy E. Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in postmenopausal women. Maturitas 1990; 12: 333-343.
  3. Kuhnz W., Gansau C., Mahler M. Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17Β-estradiol. Drug Res 1993; 43: 966-973.
  4. Stadberg E., Westlund P., Landgren B.M. et al. Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple oral doses to postmenopausalwomen. Maturitas 1999; 33: 59-69.
  5. Endrikat J., Parke S., Trummer D. et al. Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: Results of two prospective, randomized,open-label studies. Contraception 2008; 78: 3: 218-225.
  6. Sitruk-Ware R. Pharmacological profile of progestins. Maturitas 2008; 61: 1-2: 151-157.
  7. Jung-Hoffmann C., Fitzner M., Kuhl H. Oralcontraceptives containing 20 or 30 mg ethinylestradiol and 150 mg desogestrel: pharmacokineticsand pharmacodynamic parameters. Horm Res 1991; 36: 238-246.
  8. Sitruk-Ware R. New progestagens for contraceptive use. HumReprod Update 2006; 12: 169-178.
  9. Parke S., Nahum G.G., Mellinger U., Junge W. Metabolic effects of a new four-phasic oral contraceptive containing estradiol valerate and dienogest. Obstet Gynecol 2008; 111: 15S.
  10. Sitruk-Ware R.L., Menard J., Rad M., Burggraaf J., de Kam M.L., Tokay B.A. et al. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen. Contraception 2007; 75: 430-437.
  11. Odlind V., Milsom I., Persson I., Victor A. Can changes in sex hormone binding globulin predict the risk of venous thromboem-bolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand 2002; 81: 482-490.
  12. Wiegratz I., Lee J.H., Kutschera E., Winkler U.H., Kuhl H. Effect of four oral contraceptives on hemostatic parameters. Contraception 2004; 70: 97-106.
  13. Wiegratz I., Stahlberg S., Manthey T., Sänger N., Mittmann K., Lange E. et al. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2mg dienogest on various hemostasis parameters. Contraception 2008; 78: 384-391.
  14. Newburger J., Castracane V.D., Moore Jr. P.H., Williams M.C., Goldzieher J.W. The pharmacokinetics and metabolism of ethinyl estradiol and its three sulfates in the baboon. Am J Obstet Gynecol 1983; 146: 80-87.
  15. Steingold K.A., Cefalu W., Pardridge W., Judd H.L., Chaudhuri G. Enhanced hepatic extraction of estrogens used for replacement therapy. J Clin Endocrinol Metab 1986; 62: 761-766.
  16. Goebelsmann U., Mashchak C.A., Mishell Jr.D.R. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol. Am J Obstet Gynecol 1985; 151: 868-877.
  17. Kuhl H. Effects of progestogens on haemostasis. Maturitas 1996; 24: 1-19.
  18. Mashchak C.A., Lobo R.A., Dozono-Takano R., Eggena P., Nakamura R.M., Brenner P.F. et al. Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 1982; 144: 511-518.
  19. Parke S., Junge W., Mellinger U., Duijkers I., Klipping C. Oral Comparative effects of a four-phasic regimen of estradiol valerate/ dienogest versus ethinylestradiol/levonorgestrel on haemostatic parameters. Hum Reprod 2008; 23: i77.
  20. Jensen J. Evaluation of a new estradiol oral contraceptive:estradiol valerate and dienogest. Exp Opin Pharmacother 2010; 11: 1147-1157.
  21. Parke S., Nahum G.G., Mellinger U., Junge W. Metabolic effects of a new four-phasic oral contraceptive containing estradiol valerate and dienogest. Obstet Gynecol 2008; 111: 15S.
  22. Caruso S., Agnello C., Intelisano G., Farina M., Di Mari L., Cianci A. Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene. Contraception 2004; 69: 3: 237-240.
  23. Bouchard C., Brisson J., Fortier M., Morin C., Blanchette C. Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. Am J Epidemiol 2002; 156: 3: 254-261.
  24. Cayan F.J. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women. J Sex Med 2008; 5: 1: 132-138.
  25. Caruso S., Agnello C., Romano M., Cianci S., Lo Presti L., Malandrino C., Cianci A. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life. J Sex Med 2011; 8: 2841-2850.
  26. Nappi R.E., Davis S.R., Parke S., Mellinger U., Serrani M. Effects of Estradiol Valerate/Dienogest Compared with Ethinyl Estradiol/Levonorgestrel on Libido. Endocr Rev 2011; 32: 1-315.
  27. Yen and Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management , 5th edition. Chapter 14. Menopause and aging 2004; 421-452.
  28. McEwen B.S., Akama K.T., Spencer-Segal J.L., Milner T.A., Waters E.M. Estrogen effects on the brain: actions beyond the hypothalamus via novel mechanisms. Behav Neurosci 2012; 126: 1: 4-16.
  29. Walf A.A., Frye C.A. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 2006; 31: 6: 1097-1111.
  30. Gibbs R.B. Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr Rev 2010; 31: 2: 224-253.
  31. Molina R.C., Sandoval J.Z., Montero A.V., Oyarzún P.G., Molina T.G., González E.A. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents. Pediat Adolesc Gynecol 2009; 22: 1: 25-31.
  32. Ahrendt H.-J., Makalova D., Parke S., Mellinger U., Mansour D. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinylestradiol/levonorgestrel. Contraception 2009; 80: 436-44.
  33. Jordan V.C., Mittal S., Gosden B., Koch R., Lieberman M.E. Structure-activity relationships of estrogens. Environ Health Perspect 1985; 61: 97-110.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.